SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (26517)11/16/1998 12:55:00 PM
From: RXGOLF  Read Replies (1) | Respond to of 32384
 
<<We have an approval rec <<

:- ))))



To: Henry Niman who wrote (26517)11/16/1998 1:37:00 PM
From: Andrew H  Read Replies (2) | Respond to of 32384
 
Henry, any idea what the total expected dilution might be assuming LGND took advantage of all the money Elan offered to loan them say at a conversion rate of 14/share? Are we looking at about 48 million shares?

BTW, if the FDA has already approved, why is trading still halted?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News